2,781
Views
0
CrossRef citations to date
0
Altmetric
Neurology

Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 140-149 | Received 15 Oct 2020, Accepted 14 Dec 2020, Published online: 29 Jan 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.